CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

181 hedge funds and large institutions have $2.54B invested in Crinetics Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+10
Holders Change %
+5.85%
% of All Funds
2.65%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
34
Increased
75
Reduced
58
Closed
23
Calls
$22.4M
Puts
$11.9M
Net Calls
+$10.6M
Net Calls Change
+$12.5M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$144M
2
Jennison Associates
2
Jennison Associates
New York
$90.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$46.1M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$27.7M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$86M

Top Sellers

1
O
1
OrbiMed
New York
$59.3M
2
FLSM
2
Frazier Life Sciences Management
California
$14.1M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$122M
5
CC
5
Commodore Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Belvedere Trading
201
Belvedere Trading
Illinois
– -$101K -3,404 Closed
HHGC
202
Hunting Hill Global Capital
New York
– -$52.6K -1,769 Closed
Carson Wealth (CWM LLC)
203
Carson Wealth (CWM LLC)
Nebraska
– -$2K -60 Closed
Man Group
204
Man Group
United Kingdom
– -$904K – –
5 6 7 8
9